Skip to main content
Premium Trial:

Request an Annual Quote

Norvatis and Roche to UK: We Might Quit You

In the Pipeline's Derek Lowe says Novartis and Roche are employing some "hardball negotiating" in their fight with the UK government over drug pricing and clinical trial regulations. Last week, the Guardian reported that the two companies threatened to pull their research and development departments out of the UK, a move that could put as many as 5,000 people out of work. Lowe asks who benefits from this move. The news was made public through a leak, so if it came from the companies, it could be a tactic to pressure the government even more. On the other hand, if the leak came from Britain's National Health Service, the purpose could be to make the companies look bad. Either way, he says, "I think it's unlikely that this would be followed through — but neither is it completely impossible, either, which is what makes it a reasonably effective move."

The Scan

CDC Calls Delta "Variant of Concern"

CNN reports the US Centers for Disease Control and Prevention now considers the Delta variant of SARS-CoV-2 to be a "variant of concern."

From FDA to Venture Capital

Former FDA Commissioner Stephen Hahn is taking a position at a venture capital firm, leading some ethicists to raise eyebrows, according to the Washington Post.

Consent Questions

Nature News writes that there are questions whether informed consent was obtained for some submissions to a database of Y-chromosome profiles.

Cell Studies on Multimodal Single-Cell Analysis, Coronaviruses in Bats, Urban Microbiomes

In Cell this week: approach to analyze multimodal single-cell genomic data, analysis of bat coronaviruses, and more.